K954980 is an FDA 510(k) clearance for the PAGEWRITER 200, 200I CARDIOGRAPH & INTERPRETIVE CARDIO.
Submitted by Hewlett-Packard Co. (Mcminnville, US). The FDA issued a Cleared decision on May 15, 1996 after a review of 197 days - an extended review cycle.
This device falls under the Cardiovascular FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.
View all Hewlett-Packard Co. devices